Harbor Investment Advisory’s Beam Therapeutics BEAM Stock Holding History

Harbor Investment Advisory’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$30.6K	–	1346
2023 Q1	$30.6K	Hold	1,000	–	–	﹤0.01%	819
2022 Q4	$39.1K	Hold	1,000	–	–	0.01%	755
2022 Q3	$48K	Hold	1,000	–	–	0.01%	712
2022 Q2	$39K	Hold	1,000	–	–	0.01%	765
2022 Q1	$57K	Hold	1,000	–	–	0.01%	711
2021 Q4	$80K	Hold	1,000	–	–	0.01%	599
2021 Q3	$87K	Hold	1,000	–	–	0.01%	564
2021 Q2	$129K	Hold	1,000	–	–	0.02%	457
2021 Q1	$80K	Hold	1,000	–	–	0.01%	539
2020 Q4	$82K	Buy	+1,000	New	+$49.2K	0.01%	494
2020 Q3	–	Sell	-1,300	Closed	-$36K	–	1134
2020 Q2	$36K	Buy	+1,300	New	+$28K	0.01%	502

Other funds holding BEAM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harbor Investment Advisory's BEAM Position: Q2 2023 in Review

Harbor Investment Advisory sold out of Beam Therapeutics (BEAM) in Q2 2023, closing a stake of 1,000 shares — an estimated $30.6K sold.

Harbor Investment Advisory first reported a position in BEAM in Q2 2020 and held it in 11 quarters. The position peaked at $129K in Q2 2021. 193 funds tracked by Wall St. Rank hold BEAM as of Q2 2023.

Harbor Investment Advisory reported no remaining Beam Therapeutics position as of Q2 2023 after selling out during the quarter.
Harbor Investment Advisory sold 1,000 Beam Therapeutics shares in Q2 2023, an estimated $30.6K.
Harbor Investment Advisory first reported a position in Beam Therapeutics in Q2 2020 and held it in 11 quarters.
Harbor Investment Advisory's Beam Therapeutics position peaked at $129K in Q2 2021.
193 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2023.

Based on Harbor Investment Advisory's 13F filing for Q2 2023, filed 14 Jul 2023.